Media Relations
Catherine Kyroulis, WCG
Investor Relations
Robert Bennett, Executive Director of Investor Relations & Communications
investorrelations@biocryst.com
Resources
- BioCryst press releases
- Learn about our leadership team
- View our current pipeline
BioCryst designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. Learn more about our Company
